Cetylpyridinium chloride
important information for the patient.
This medicine should always be taken exactly as described in the patient leaflet or as directed by
a doctor or pharmacist.
Halset contains cetylpyridinium chloride. The medicine acts locally as a disinfectant in inflammation of the
mouth and throat. It has a bactericidal effect on Gram-positive and Gram-negative bacteria and also acts on
some fungi. Halset does not contain sugar.
Halset is used preventively and therapeutically for mild and moderate inflammatory conditions of the mouth and
throat.
If there is no improvement or the patient feels worse after 3 days, they should consult their doctor.
Halset should not be used in children due to the risk of accidental choking on the lozenge.
Before starting to take Halset, the patient should discuss it with their doctor or pharmacist.
The patient should tell their doctor or pharmacist about all medicines they are taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
There is no data on the effect of the medicine on the ability to drive and use machines.
One lozenge contains 742.35 mg of sorbitol. If the patient has previously been diagnosed with intolerance to certain sugars, they should consult their doctor before taking the medicine (see section When Not to Take Halset). The caloric value is 2.6 kcal/g sorbitol.
This medicine should always be taken exactly as described in the patient leaflet or as directed by
a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
Halset lozenges should be taken orally.
The lozenge should be sucked slowly.
The recommended dose is:
Adults and adolescents:suck 1 lozenge every 1-2 hours (maximum 8 lozenges per day).
Children over 6 years of age:suck 1 lozenge every 2-3 hours (maximum 6 lozenges per day).
Taking more Halset lozenges than recommended may cause irritation of the mucous membranes of the mouth, diarrhea (especially in children), nausea, vomiting.
In case of taking more than the recommended dose, the patient should consult their doctor or pharmacist.
A double dose should not be taken to make up for a missed dose.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rarely, allergic reactions (e.g., hives, rash), burning sensation in the mouth, nausea, and transient taste disturbances occur.
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The medicine should be stored at a temperature below 25°C.
The medicine should not be used after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Lozenges.
Halset lozenges are rectangular, flat on both sides, with a smooth surface, rounded corners and edges, white, with a gloss, sweet, minty flavor, and menthol aroma.
Pack sizes: 6, 12, 18, or 24 lozenges.
BIOFARM Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
Poland
Tel. 061 66 51 500
To obtain more detailed information, the patient should contact the local representative of the marketing authorization holder:
Poland
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
Poland
Tel. 061 66 51 500
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.